Carlsmed (CARL) Cash from Operations (2024 - 2026)

Carlsmed (CARL) has reported Cash from Operations for 3 consecutive years, with -$7.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 4.49% year-over-year to -$7.4 million; the trailing twelve-month figure through Jun 2026 stood at -$34.1 million (down 26.56% YoY), and the FY2025 full-year result was -$29.0 million, down 13.79% from the prior year.
• Cash from Operations grew to -$7.4 million in Q2 2026 per CARL's latest filing, from -$13.0 million in the prior quarter.
• Across five years, Cash from Operations topped out at -$4.2 million in Q4 2024 and bottomed at -$13.0 million in Q1 2026.
• Historically, Cash from Operations has averaged -$7.6 million across 3 years, with a median of -$7.5 million in 2024.
• The widest YoY moves for Cash from Operations: up 4.49% in 2026, down 59.5% in 2026.
• Over 3 years, Cash from Operations stood at -$4.2 million in 2024, then declined by 26.6% to -$5.3 million in 2025, then plunged by 38.28% to -$7.4 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$7.4 million, -$13.0 million, and -$5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.